Fosinopril Sodium
Product Images NDC 50436-0274

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Fosinopril Sodium (NDC 50436-0274). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

29914956-figure-01 (29914956 Figure 01)

Chemical structure of fosinopril sodium showing its molecular connectivity, including aromatic, cycloalkane, and phosphate functional groups in the molecule.*

FDA Label Image

29914956-figure-02 (29914956 Figure 02)

A table comparing the incidence and discontinuation rates of clinical adverse events in placebo-controlled hypertension trials for Fosinopril Sodium and placebo. It lists rates for cough, dizziness, and nausea/vomiting among subjects taking Fosinopril Sodium (N=688) versus placebo (N=184).*

FDA Label Image

29914956-figure-03 (29914956 Figure 03)

A data table titled 'Clinical Adverse Events in Placebo-Controlled Trials (Heart Failure)' showing incidence and discontinuation rates for Fosinopril Sodium (N=361) and placebo (N=373). The table lists adverse events including dizziness, cough, hypotension, musculoskeletal pain, nausea/vomiting, and diarrhea, with percentages for both incidence and discontinuation rates.*

FDA Label Image

29914956-figure-04 (29914956 Figure 04)

A data table comparing the incidence and discontinuation rates of adverse events in patients taking Fosinopril Sodium (N=361) versus placebo (N=373). Events listed include chest pain, upper respiratory infection, orthostatic hypotension, subjective cardiac rhythm disturbance, and weakness, with numerical values for each group.*

FDA Label Image

Label Image (50436 0274)

Fosinopril Sodium 40 mg tablets in a blister pack labeled for a 30-count package. The label includes the National Drug Code (NDC) 50436-0274-1 and indicates manufacturing by Camber. It features warnings to keep out of reach of children and storage instructions between 20-25°C. The labeler is Unit Dose Services, LLC, with an NDC of 50436-0274 and a listed address in Farmington, CT.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.